HK1219886A1 - 帶包衣的去氧腎上腺素顆粒及其在藥物製劑中的用途 - Google Patents

帶包衣的去氧腎上腺素顆粒及其在藥物製劑中的用途

Info

Publication number
HK1219886A1
HK1219886A1 HK16107943.5A HK16107943A HK1219886A1 HK 1219886 A1 HK1219886 A1 HK 1219886A1 HK 16107943 A HK16107943 A HK 16107943A HK 1219886 A1 HK1219886 A1 HK 1219886A1
Authority
HK
Hong Kong
Prior art keywords
pharmaceutical formulations
coated phenylephrine
phenylephrine particles
particles
coated
Prior art date
Application number
HK16107943.5A
Other languages
English (en)
Inventor
Lee Der-Yang
Chen Vincent
Shen Robert
Original Assignee
Johnson & Johnson Consumer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johnson & Johnson Consumer Inc filed Critical Johnson & Johnson Consumer Inc
Publication of HK1219886A1 publication Critical patent/HK1219886A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
HK16107943.5A 2013-03-15 2016-07-07 帶包衣的去氧腎上腺素顆粒及其在藥物製劑中的用途 HK1219886A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13/832,797 US20140271893A1 (en) 2013-03-15 2013-03-15 Coated phenylephrine particles and use thereof in pharmaceutical formulations
PCT/US2014/019311 WO2014149529A1 (en) 2013-03-15 2014-02-28 Coated phenylephrine particles and use thereof in pharmaceutical formulations

Publications (1)

Publication Number Publication Date
HK1219886A1 true HK1219886A1 (zh) 2017-04-21

Family

ID=50288314

Family Applications (1)

Application Number Title Priority Date Filing Date
HK16107943.5A HK1219886A1 (zh) 2013-03-15 2016-07-07 帶包衣的去氧腎上腺素顆粒及其在藥物製劑中的用途

Country Status (18)

Country Link
US (1) US20140271893A1 (zh)
EP (1) EP2968188B1 (zh)
JP (1) JP6373957B2 (zh)
CN (1) CN105246466B (zh)
AR (1) AR095526A1 (zh)
AU (1) AU2014238062B2 (zh)
BR (1) BR112015022945B1 (zh)
CA (1) CA2906363C (zh)
HK (1) HK1219886A1 (zh)
IL (1) IL241051B (zh)
MX (1) MX2015012635A (zh)
NZ (1) NZ712318A (zh)
PH (1) PH12015502015A1 (zh)
RU (1) RU2681312C2 (zh)
SA (1) SA515361065B1 (zh)
UA (1) UA120251C2 (zh)
WO (1) WO2014149529A1 (zh)
ZA (1) ZA201507676B (zh)

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2990332A (en) 1958-04-02 1961-06-27 Wallace & Tiernan Inc Pharmaceutical preparations comprising cation exchange resin adsorption compounds and treatment therewith
US4221778A (en) 1979-01-08 1980-09-09 Pennwalt Corporation Prolonged release pharmaceutical preparations
GB8707421D0 (en) * 1987-03-27 1987-04-29 Wellcome Found Pharmaceutical formulations
ATE406872T1 (de) 1996-12-20 2008-09-15 Mcneil Ppc Inc Durch ionenaustauscherharze verabreichte hustenmittel
PL366089A1 (en) * 2000-03-30 2005-01-24 Bristol-Myers Squibb Company Sustained release beadlets containing stavudine
US20030190343A1 (en) * 2002-03-05 2003-10-09 Pfizer Inc. Palatable pharmaceutical compositions for companion animals
US20050266032A1 (en) 2003-12-17 2005-12-01 Sovereign Pharmaceuticals, Ltd. Dosage form containing multiple drugs
US9492541B2 (en) 2004-09-14 2016-11-15 Sovereign Pharmaceuticals, Llc Phenylepherine containing dosage form
US7639628B2 (en) 2005-07-14 2009-12-29 University Of Notre Dame Du Lac Response time detection in a network having shared interfaces
EP2428205B1 (en) 2006-03-16 2012-10-03 Tris Pharma, Inc. Modified release formulations containing drug-ion exchange resin complexes
NZ573174A (en) 2006-06-01 2012-01-12 Msd Consumer Care Inc Sustained release pharmaceutical dosage form containing phenylephrine
PE20080330A1 (es) 2006-06-01 2008-04-25 Schering Corp Composiciones farmaceuticas para la liberacion sostenida de fenilefrina
RU2009101309A (ru) * 2006-06-19 2010-07-27 МакНЕЙЛ-ППС, ИНК. (US) Частицы с энтеросолюбильным покрытием, содержащие активный ингредиент
WO2008064192A2 (en) * 2006-11-21 2008-05-29 Mcneil-Ppc, Inc. Modified release analgesic suspensions
US9833510B2 (en) * 2007-06-12 2017-12-05 Johnson & Johnson Consumer Inc. Modified release solid or semi-solid dosage forms
CA2729015A1 (en) * 2008-06-26 2009-12-30 Mcneil-Ppc, Inc. Coated particles containing pharmaceutically active agents
PE20131101A1 (es) * 2010-08-13 2013-09-23 Euro Celtique Sa Formulaciones estables al almacenamiento de oxicodona y naloxona
RU2477741C1 (ru) * 2012-04-27 2013-03-20 Юрий Васильевич Захаров Состав мульчирующего покрытия (варианты)

Also Published As

Publication number Publication date
JP2016516029A (ja) 2016-06-02
US20140271893A1 (en) 2014-09-18
WO2014149529A1 (en) 2014-09-25
MX2015012635A (es) 2016-08-03
UA120251C2 (uk) 2019-11-11
EP2968188A1 (en) 2016-01-20
PH12015502015B1 (en) 2016-01-11
ZA201507676B (en) 2017-11-29
JP6373957B2 (ja) 2018-08-15
AU2014238062A1 (en) 2015-09-17
RU2681312C2 (ru) 2019-03-06
CA2906363C (en) 2021-03-16
AR095526A1 (es) 2015-10-21
BR112015022945B1 (pt) 2022-11-01
BR112015022945A8 (pt) 2022-08-09
CN105246466A (zh) 2016-01-13
SA515361065B1 (ar) 2017-02-02
EP2968188B1 (en) 2017-04-19
NZ712318A (en) 2020-05-29
RU2015144045A (ru) 2017-04-20
BR112015022945A2 (pt) 2017-07-18
PH12015502015A1 (en) 2016-01-11
AU2014238062B2 (en) 2018-11-29
IL241051A0 (en) 2015-11-30
IL241051B (en) 2018-06-28
CA2906363A1 (en) 2014-09-25
CN105246466B (zh) 2018-03-30

Similar Documents

Publication Publication Date Title
HK1224286A1 (zh) 二氫嘧啶類化合物及其在藥物中的應用
HK1217409A1 (zh) 塗佈的顆粒和包括其的組合物
HK1210065A1 (zh) 乾粉末藥物傳遞系統和方法
HK1205690A1 (zh) 藥物组合物及其施用
IL263978B (en) Amorphous latrovir and solid pharmaceutical preparations containing it and its uses
SG11201408545RA (en) Polymer particles and use thereof
AP2016009221A0 (en) Strigolactone formulations and uses thereof
HK1182374A1 (zh) γ- 種γ-氧化鋁顆粒及其製備方法
EP2842945A4 (en) SULFONAMIDE DERIVATIVE AND MEDICAL USE THEREOF
EP2961433A4 (en) PEPTIDE-BASED HYDROGEL PARTICLES AND USES THEREOF
HK1215388A1 (zh) 可吸入藥用組合物和含有該藥用組合物的吸入器裝置
EP2718283A4 (en) INDAZOLE AND PYRROLOPYRIDINE DERIVATIVE AND PHARMACEUTICAL USE THEREOF
PL3064491T3 (pl) Pochodna sulfonamidowa i jej zastosowanie medyczne
IL244901A0 (en) Derivatives of aminotetralin and aminoindan, pharmaceutical compositions containing them and their use in therapy
EP3006431A4 (en) TIZOXANID CARBAMATE AND PHARMACEUTICAL USE THEREOF
IL246167A0 (en) Formulations of berberine and their uses
IL240666A0 (en) Pharmaceutical preparations for oral administration and their uses
HK1219691A1 (zh) 醫藥組成物及其用途
HK1215167A1 (zh) 可吸入藥用組合物和含有該藥用組合物的吸入器裝置
GB201307082D0 (en) Pharmaceutical composition comprising 15-HETrE and methods of using the same
ZA201507673B (en) Phenylephrine resinate particles and use thereof in pharmaceutical formulations
HK1219886A1 (zh) 帶包衣的去氧腎上腺素顆粒及其在藥物製劑中的用途
HK1218624A1 (zh) 納米粒子和微粒子製劑
EP3055286A4 (en) 4-methylsulfonyl-2-butenenitrile and its pharmaceutical use
PL2830641T3 (pl) Nowe ekstrakty waleriany i ich zastosowania

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20220226